Healthcare


 Australian Clinical Labs Mid-Year 2025 Earnings: Revenues Surpass Expectations, EPS Falls Short

Australian Clinical Labs Mid-Year 2025 Earnings: Revenues Surpass Expectations, EPS Falls Short

March 01, 2025 03:38 PM AEDT| By Team Kalkine Media

Highlights:,Revenue rises significantly from the previous year’s first half.,Net income records a sharp increase, reflecting improved financial performance.,Share price declines over the past week despite positive earnings.,Australian Clinical Labs (...

 Ansell (ASX:ANN) Needs Further Efforts to Increase Its Value Moving Forward

Ansell (ASX:ANN) Needs Further Efforts to Increase Its Value Moving Forward

March 01, 2025 03:31 PM AEDT| By Team Kalkine Media

Highlights,Ansell's return on capital employed remains steady within its sector.,The company has expanded its capital base without a corresponding rise in efficiency.,Market valuation has increased despite unchanged returns on capital.,Ansell (ASX:AN...

 ASX Healthcare Sector Sees Strong Interest from Asian Investors

ASX Healthcare Sector Sees Strong Interest from Asian Investors

March 01, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,ASX healthcare stocks offer a unique entrepreneurial opportunity, appealing to Asian investors seeking diversification and higher returns.,The ASX market boasts strong liquidity and more lenient listing requirements compared to other Asian...

 We Conducted a Stock Analysis Focused on Earnings Growth and Found That Austco Healthcare (ASX:AHC) Excelled Effortlessly

We Conducted a Stock Analysis Focused on Earnings Growth and Found That Austco Healthcare (ASX:AHC) Excelled Effortlessly

March 01, 2025 09:35 AM AEDT| By Team Kalkine Media

Highlights:,Earnings per share have shown consistent growth over recent years.,Revenue and EBIT margins have seen positive momentum.,Leadership holds a significant ownership stake, indicating strong alignment with company objectives.,Austco Healthcar...

 Moderate Expansion for Ecofibre Limited (ASX:EOF) Contributes to 26% Drop in Stock Price

Moderate Expansion for Ecofibre Limited (ASX:EOF) Contributes to 26% Drop in Stock Price

March 01, 2025 09:30 AM AEDT| By Team Kalkine Media

Highlights:,Ecofibre's share price has experienced a significant downturn in recent months.,The company's price-to-sales ratio remains notably lower than industry standards.,Revenue growth remains a concern compared to broader sector expectations.,Ec...

 Dimerix Reports Increased Net Loss for First Half of 2025

Dimerix Reports Increased Net Loss for First Half of 2025

February 28, 2025 03:53 PM AEDT| By Team Kalkine Media

Highlights:,Financial Performance:,Dimerix recorded a widened net loss, reflecting an increase compared to the previous reporting period.,Share Movement:,The company's stock experienced a decline over the past week.,Market Developments:,Financial res...

 Global Health's Half-Year Results and Insights

Global Health's Half-Year Results and Insights

February 28, 2025 03:52 PM AEDT| By Team Kalkine Media

Highlights,Global Health's revenue increased by 7.3% over the previous year.,The company narrowed its net losses by 39% compared to last year.,Stock prices saw a decline of 13% over the past week.,Global Health (ASX:GLH) recently unveiled its financi...

 Universal Biosensors Full Year 2024 Earnings Report: A loss of AU$0.053 per share, compared to a loss of AU$0.032 per share in FY 2023.

Universal Biosensors Full Year 2024 Earnings Report: A loss of AU$0.053 per share, compared to a loss of AU$0.032 per share in FY 2023.

February 28, 2025 03:51 PM AEDT| By Team Kalkine Media

Highlights,Revenue decreased by 5.3% from the previous financial year.,Net loss expanded to AU$14.2 million.,Shares have declined by 7.7% over the past week.,Universal Biosensors (ASX:UBI) has reported its full-year financial results for 2024, reveal...

 Before Purchasing Sonic Healthcare Limited (ASX:SHL) for Its Upcoming Dividend, Consider These Important Checks

Before Purchasing Sonic Healthcare Limited (ASX:SHL) for Its Upcoming Dividend, Consider These Important Checks

February 28, 2025 03:48 PM AEDT| By Team Kalkine Media

Highlights,Sonic Healthcare’s upcoming ex-dividend date is approaching.,A dividend has been declared at a value per share.,Dividend payout levels highlight sustainability considerations.,Sonic Healthcare (ASX:SHL) operates within the healthcare secto...

 Sonic Healthcare's (ASX:SHL) Upcoming Dividend: Key Factors to Consider

Sonic Healthcare's (ASX:SHL) Upcoming Dividend: Key Factors to Consider

February 28, 2025 01:00 PM AEDT| By Team Kalkine Media

Highlights,Ex-dividend date approaching:,Investors need to be aware of the March 5 deadline to be eligible for the next dividend.,Dividend sustainability concerns:,High payout ratio raises questions about long-term dividend stability.,Earnings growth...

 ECS Botanics (ASX:ECS) Eyes Global Expansion Amid Revenue Decline and Industry Shifts

ECS Botanics (ASX:ECS) Eyes Global Expansion Amid Revenue Decline and Industry Shifts

February 28, 2025 11:39 AM AEDT| By Team Kalkine Media

Highlights,Revenue declined by 16% due to increased competition and regulatory shifts.,Expansion into export markets, product innovation, and cost reductions drive future potential.,Leadership restructuring aims to enhance operational efficiency.,ECS...

 ASX Healthcare Sector Faces Challenges Amidst Volatility

ASX Healthcare Sector Faces Challenges Amidst Volatility

February 28, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,The ASX healthcare sector experienced one of its worst reporting seasons, with over 50% of companies showing negative stock reactions.,Ramsay Health Care (ASX:RHC) saw a notable 8% share price increase due to strong performance in Australi...

 Biotech Developments: Key Approvals and Market Prospects

Biotech Developments: Key Approvals and Market Prospects

February 28, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Telix Pharmaceuticals expands into Brazil with Illuccix approval, tapping into a large prostate cancer market.,Orthocell secures approval in Singapore for Striate, boosting access in the ASEAN market.,Neurizon Therapeutics set to resume AL...

 Institutional Ownership in Australian Clinical Labs Limited (ASX:ACL)

Institutional Ownership in Australian Clinical Labs Limited (ASX:ACL)

February 27, 2025 04:26 PM AEDT| By Team Kalkine Media

Highlights,Institutional investors hold a significant stake in Australian Clinical Labs, shaping its strategic direction.,The largest shareholders include a mix of institutions, hedge funds, and company insiders.,The general public also holds a subst...

 EZZ Life Science Holdings: Financial Performance and Leadership Insight

EZZ Life Science Holdings: Financial Performance and Leadership Insight

February 27, 2025 01:39 PM AEDT| By Team Kalkine Media

Highlights:,Earnings per share for EZZ Life Science Holdings has shown consistent growth.,Company leadership holds a significant portion of shares, reinforcing confidence.,CEO's remuneration remains aligned with financial performance and company dire...

 Ownership Structure of Integral Diagnostics and Its Market Influence

Ownership Structure of Integral Diagnostics and Its Market Influence

February 27, 2025 01:37 PM AEDT| By Team Kalkine Media

Highlights:,Individual investors control the largest portion of Integral Diagnostics' shares.,Institutional ownership reflects significant interest in the company.,Private companies and insiders hold smaller stakes in the business.,Integral Diagnosti...

 Should You Be Concerned About CleanSpace Holdings' (ASX:CSX) Debt Despite the Lack of Earnings?

Should You Be Concerned About CleanSpace Holdings' (ASX:CSX) Debt Despite the Lack of Earnings?

February 27, 2025 01:32 PM AEDT| By Team Kalkine Media

Highlights:,CleanSpace Holdings maintains more liquid assets than liabilities, with a strong cash position.,The company reports steady revenue growth, reflecting an expanding market presence.,A net cash balance underscores financial stability, reduci...

 Investors who put their money into Genetic Signatures (ASX:GSS) three years ago are still facing a 51% loss, despite seeing a 16% increase over the past week.

Investors who put their money into Genetic Signatures (ASX:GSS) three years ago are still facing a 51% loss, despite seeing a 16% increase over the past week.

February 27, 2025 01:31 PM AEDT| By Team Kalkine Media

Highlights:,The stock price of Genetic Signatures Limited has experienced an upward movement this week.,Over the past several years, revenue has shown a downward trend, impacting overall stock performance.,Recent share acquisitions by company insider...

 Neuren Pharmaceuticals Reports Record Sales Growth for Rett Syndrome Drug

Neuren Pharmaceuticals Reports Record Sales Growth for Rett Syndrome Drug

February 27, 2025 12:21 PM AEDT| By Team Kalkine Media

Highlights,Neuren,Pharmaceuticals (NEU) sees a 97% surge in full-year sales for Rett syndrome drug DAYBUE™.,Acadia Pharmaceuticals (,NASDAQ:ACAD,) reports record quarterly and full-year sales in the US.,Forecasted royalties for,Neuren,Pharmaceuticals...

 Monash IVF Group (ASX:MVF) Delivers Strong Performance with Double-Digit Revenue Growth in 1H25

Monash IVF Group (ASX:MVF) Delivers Strong Performance with Double-Digit Revenue Growth in 1H25

February 27, 2025 12:09 PM AEDT| By Team Kalkine Media

Highlights,Revenue surged 11.6% to $140.3 million in the first half of 2025.,Underlying,NPAT increased by 5.5% to $15.8 million,Expanding fertility services with new specialists and infrastructure projects.,Monash IVF Group (ASX:MVF) has reported a s...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.